Trials / Conditions / Stage IA Pancreatic Cancer AJCC v8
Stage IA Pancreatic Cancer AJCC v8
5 registered clinical trials studyying Stage IA Pancreatic Cancer AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borde NCT04940286 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer NCT05055323 | Thomas Jefferson University | Phase 1 |
| Active Not Recruiting | A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma NCT04111172 | Thomas Jefferson University | Phase 2 |
| Terminated | Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer NCT04400903 | OHSU Knight Cancer Institute | — |
| Completed | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study NCT04449679 | Thomas Jefferson University | N/A |